Biotherapeutic Department and Hematology Department of Chinese PLA General Hospital
Biotherapeutic Department and Hematology Department of Chinese PLA General Hospital
Beijing, Beijing Municipality, China2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| PIN in Combination With Sintilimab in Previously Treated pMMR/MSS CRC With Hepatic Metastases | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder | Not yet recruiting | Phase 1 | 2026-02-17 | NCT07411781 | |
| Chidamide+Decitabine Plus Anti-PD-1 Antibody for Patients With R/R cHL Who Are Transplant-ineligible or Refused Transplant. | Ineligible Or Refused Transplant Patients With Classical Hodgkin Lymphoma | Not yet recruiting | Phase 2 | 2024-08-21 | NCT06563778 |